SpectraWAVE Raises $50M Round for Intravascular Imaging Tech
Medical imaging company SpectraWAVE, Inc. has raised an oversubscribed $50 million Series B funding to support commercial expansion and product additions for the company’s HyperVue imaging system.
HyperVue technology combines DeepOCT and near-IR spectroscopy into an AI-driven workflow and image analysis offering. The platform was developed for intravascular imaging applications such as coronary stenting procedures, plaque morphology, and future adverse event risk, among others.
Additionally, according to SpectraWAVE CEO Eman Namati, the company is currently in development on a wire-free physiology software addition for the HyperVue. The software would allow physicians to rapidly assess pressure drops in a patient’s coronary arteries by using the product's hardware, the company said.
Johnson & Johnson Innovation led the funding round.
LATEST NEWS
- Method Measures Trapped Qubits While Keeping Others Safe, Close
Sep 26, 2024
- Industrial Laser-Driven Neutron Source Developed for Nondestructive Assessment of Nuclear Waste
Sep 26, 2024
- Glass-Based PICs Developer Expands Following NATO-Supported Funding
Sep 25, 2024
- InZiv Appoints Vice President of R&D: People in the News: 9/25/24
Sep 25, 2024
- Ansys, TSMC, Collaborate with Microsoft on High-Speed Optical Data Transfer
Sep 25, 2024
- Collaboration, Tech Advancement Take Center Stage at Neuroscience 2024
Sep 24, 2024
- HyperLight Lands $37M to Advance Lithium Niobate Tech
Sep 24, 2024
- Integrated Photonics Companies Join Forces, Target Hybrid Solutions Supply Chain
Sep 24, 2024